Hypervirulent Klebsiella pneumoniae-related bacteremia in intensive care unit: A retrospective cohort study
Related Experiment Video
Updated: Jun 30, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Marin Moutel1, Edwidge Peju2, Martin Belan3
1Équipe mobile d'infectiologie, Hôpitaux Universitaires Paris Centre-Cochin Port Royal, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Introduction:
Hypervirulent Klebsiella pneumoniae (hvKP) bloodstream infections (BSI) have rarely been reported in critically ill patients.
Methods:
We conducted a retrospective study of KP-BSI between January 2016 and December 2020 in an adult medical intensive care unit (ICU) of our tertiary care hospital. Hypervirulent phenotype was defined by the detection of both rmpA and iutA.
Results:
Seventy patients diagnosed with K. pneumonia BSI were included, of whom 9 (13 %) had hvKP infection. Pneumonia accounted for 56 % of hvKP-BSI and for 28 % of those with cKP. Fifty-six percent of patients with hvKP-BSI were homeless, versus 2 % of those with cKP-BSI (p < 0.001). The 30-day mortality rate reached 44 % for hvKP-BSI and 34 % for cKP-BSI (p = 0.7) and did not appear related to the hypervirulent phenotype in multivariable analysis.
Discussion:
We here evidenced a new clinical entity of hvKP-BSI associated with pulmonary infection in homeless patients, which exhibits high mortality.
Insights
Hypervirulent Klebsiella pneumoniae bloodstream infections (hvKP-BSI) are rare in the ICU. This study found hvKP-BSI disproportionately affects homeless patients with pneumonia, showing high mortality.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Hypervirulent Klebsiella pneumoniae (hvKP) bloodstream infections (BSI) are infrequently documented in critically ill patients.
- Klebsiella pneumoniae bloodstream infections (KP-BSI) represent a significant clinical challenge.
Purpose of the Study:
- To investigate the characteristics and outcomes of hvKP-BSI in an adult medical intensive care unit (ICU).
- To identify risk factors and clinical presentations associated with hvKP-BSI.
Main Methods:
- Retrospective study of KP-BSI cases from January 2016 to December 2020 in a tertiary care hospital ICU.
- Hypervirulent phenotype defined by the presence of rmpA and iutA genes.
- Comparison of clinical data between hvKP-BSI and classical KP-BSI (cKP-BSI) cohorts.
Main Results:
- Nine out of seventy (13%) KP-BSI cases were identified as hvKP-BSI.
- hvKP-BSI was significantly associated with pneumonia (56% vs 28%) and homelessness (56% vs 2%).
- 30-day mortality was 44% for hvKP-BSI and 34% for cKP-BSI, not statistically different in multivariable analysis.
Conclusions:
- A distinct clinical entity of hvKP-BSI associated with pulmonary infections in homeless individuals has been identified.
- This hvKP-BSI presentation is linked to high mortality rates.
- Further research is needed to understand the specific mechanisms and optimal management strategies for this population.
More Related Videos
05:52Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
Published on: January 7, 2019
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...